Orchid Pharma Limited (NSE:ORCHPHARMA) — Stock Price
Orchid Pharma Limited (NSE:ORCHPHARMA) is currently trading at Rs1079.15 INR, up 7.72% today. Over the past 52 weeks, shares have ranged between Rs482.45 and Rs1101.40. This page tracks Orchid Pharma Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Orchid Pharma Limited.
Orchid Pharma Limited (ORCHPHARMA) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Orchid Pharma Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Orchid Pharma Limited Income Statement — Revenue, Profit & Earnings by Year
Orchid Pharma Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | Rs8.11 Billion | Rs9.22 Billion | Rs8.19 Billion | Rs6.66 Billion | Rs5.60 Billion |
| Cost of Revenue | Rs6.53 Billion | Rs5.67 Billion | Rs6.83 Billion | Rs5.95 Billion | Rs3.27 Billion |
| Gross Profit | Rs1.59 Billion | Rs3.55 Billion | Rs1.36 Billion | Rs706.89 Million | Rs2.32 Billion |
| Research & Development | — | Rs83.67 Million | Rs70.94 Million | Rs63.62 Million | Rs66.26 Million |
| SG&A | — | Rs323.37 Million | Rs84.26 Million | Rs87.86 Million | Rs86.41 Million |
| Total Operating Expenses | Rs1.53 Billion | Rs1.21 Billion | Rs584.47 Million | Rs410.20 Million | Rs2.66 Billion |
| Operating Income | Rs56.76 Million | Rs811.13 Million | Rs777.04 Million | Rs296.69 Million | Rs-338.90 Million |
| EBITDA | Rs56.76 Million | Rs1.45 Billion | Rs1.42 Billion | Rs1.43 Billion | Rs621.38 Million |
| EBIT | — | Rs1.10 Billion | Rs1.09 Billion | Rs881.49 Million | Rs-248.87 Million |
| Interest Expense | Rs132.59 Million | Rs145.40 Million | Rs167.36 Million | Rs329.02 Million | Rs334.56 Million |
| Income Before Tax | Rs203.55 Million | Rs994.63 Million | Rs890.47 Million | Rs552.47 Million | Rs-568.99 Million |
| Income Tax Expense | Rs-1.92 Million | Rs-1.94 Million | Rs-31.19 Million | Rs21.54 Million | Rs35.23 Million |
| Net Income | Rs205.47 Million | Rs996.57 Million | Rs921.66 Million | Rs463.18 Million | Rs-19.51 Million |
Orchid Pharma Limited Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Orchid Pharma Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | Rs19.11 Billion | Rs16.88 Billion | Rs15.54 Billion | Rs12.25 Billion | Rs11.11 Billion |
| Total Current Assets | Rs6.84 Billion | Rs8.07 Billion | Rs7.91 Billion | Rs5.01 Billion | Rs3.98 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | Rs770.66 Million | Rs1.55 Billion | Rs9.23 Million | Rs40.15 Million | Rs59.00K |
| Net Receivables | Rs2.64 Billion | Rs2.42 Billion | Rs2.00 Billion | Rs2.15 Billion | Rs1.71 Billion |
| Inventory | Rs2.56 Billion | Rs3.26 Billion | Rs2.64 Billion | Rs2.29 Billion | Rs1.73 Billion |
| Property, Plant & Equipment | — | — | — | — | Rs5.93 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Rs6.23 Billion | Rs4.21 Billion | Rs3.84 Billion | Rs5.37 Billion | Rs4.63 Billion |
| Total Current Liabilities | Rs2.79 Billion | Rs2.86 Billion | Rs2.60 Billion | Rs3.72 Billion | Rs2.41 Billion |
| Long-term Debt | Rs3.28 Billion | Rs1.32 Billion | Rs1.20 Billion | Rs1.49 Billion | Rs2.08 Billion |
| Net Debt | Rs3.56 Billion | Rs1.54 Billion | Rs1.32 Billion | Rs3.09 Billion | Rs2.64 Billion |
| Total Stockholder Equity | Rs12.88 Billion | Rs12.67 Billion | Rs11.69 Billion | Rs6.89 Billion | Rs6.47 Billion |
| Retained Earnings | — | Rs-20.78 Billion | Rs-21.77 Billion | Rs-22.68 Billion | Rs-23.14 Billion |
Orchid Pharma Limited Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Orchid Pharma Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs1.10 Billion | Rs192.15 Million | Rs1.26 Billion | Rs183.38 Million | Rs924.75 Million |
| Capital Expenditures | Rs3.84 Billion | Rs1.50 Billion | Rs648.15 Million | Rs849.13 Million | Rs144.03 Million |
| Free Cash Flow | Rs-2.74 Billion | Rs-1.31 Billion | Rs611.77 Million | Rs-665.75 Million | Rs780.71 Million |
| Investing Cash Flow | Rs-2.96 Billion | Rs-269.31 Million | Rs-3.12 Billion | Rs-312.14 Million | Rs1.13 Billion |
| Financing Cash Flow | Rs1.72 Billion | Rs252.22 Million | Rs1.67 Billion | Rs311.66 Million | Rs-2.17 Billion |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Rs354.53 Million | Rs345.46 Million | Rs332.37 Million | Rs547.87 Million | Rs870.25 Million |
| Change in Cash | Rs589.88 Million | Rs175.06 Million | Rs-189.96 Million | Rs182.91 Million | Rs-113.87 Million |
Orchid Pharma Limited Earnings History — EPS Actual vs. Analyst Estimates
Track Orchid Pharma Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 25, 2026 | 4.58 | 3.00 | +52.67% |
| Feb 11, 2026 | -1.08 | -0.30 | -260.00% |
| Nov 11, 2025 | -1.13 | 2.90 | -138.97% |
| Aug 11, 2025 | — | — | — |
| May 26, 2025 | 4.40 | 4.40 | +0.00% |
| Feb 12, 2025 | 4.10 | 6.30 | -34.92% |
| Nov 11, 2024 | 5.37 | 4.00 | +34.25% |
| Aug 12, 2024 | 5.79 | 6.90 | -16.09% |